This rapid interim guidance was archived after planned review on 16 September 2021 as it is no longer considered valid now that services have adapted to ways of working in the current COVID-19 situation. Please refer to standard guidance in the BHIVA antiretroviral treatment guidelines.
This updated version, released on 8 August 2020, replaced the first version which was released on 1 May 2020.